Role of Glycogen Synthase Kinase-3β Inhibitor AZD1080 in Ovarian Cancer

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s102506
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Glycogen Synthase Kinase-3

International Journal of Alzheimer's Disease
AgingCognitive NeuroscienceMolecular NeuroscienceNeurologyBehavioral NeuroscienceCellular
2011English

Clinicopathological and Biological Significance of Aberrant Activation of Glycogen Synthase Kinase-3 in Ovarian Cancer

OncoTargets and Therapy
OncologyPharmacology
2014English

Role of Cystathionine Beta Synthase in Lipid Metabolism in Ovarian Cancer

Oncotarget
Oncology
2015English

The Role of Glycogen Synthase Kinase 3 in the Transformation of Epidermal Cells

Cancer Research
Cancer ResearchOncology
2007English

Glycogen Synthase Kinase-3 in Neurodegeneration and Neuroprotection:Lessons From Lithium

Current Alzheimer Research
Neurology
2007English

Glycogen Synthase Kinase 3 in MLL Leukaemia Maintenance and Targeted Therapy

Nature
Multidisciplinary
2008English

Glycogen Synthase Kinase-3 Is a Negative Regulator of Extracellular Signal-Regulated Kinase

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

Bacillus Anthracis Edema Toxin Activates Nuclear Glycogen Synthase Kinase 3

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2008English

Computer-Aided Molecular Design of Pyrazolotriazines Targeting Glycogen Synthase Kinase 3

Journal of Enzyme Inhibition and Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy